Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation. | Nat Commun | 2022 | 35365657 | PubTator, text mining | PubMed |
| Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes. | Stem Cell Res Ther | 2022 | 35365232 | PubTator, text mining | PubMed |
| Bioartificial pulsatile cuffs fabricated from human induced pluripotent stem cell-derived cardiomyocytes using a pre-vascularization technique. | NPJ Regen Med | 2022 | 35361794 | PubTator, text mining | PubMed |
| Genetics of cancer therapy-associated cardiotoxicity. | J Mol Cell Cardiol | 2022 | 35358500 | PubTator, text mining | PubMed |
| Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics. | Nat Commun | 2022 | 35354815 | PubTator, text mining | PubMed |
| Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity. | Cell Death Discov | 2022 | 35347130 | PubTator, text mining | PubMed |
| Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling. | Rev Cardiovasc Med | 2022 | 35345275 | PubTator, text mining | PubMed |
| Hgs Deficiency Caused Restrictive Cardiomyopathy via Disrupting Proteostasis. | Int J Biol Sci | 2022 | 35342336 | PubTator, text mining | PubMed |
| Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy. | Sci Rep | 2022 | 35338173 | PubTator, text mining | PubMed |
| A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | Viruses | 2022 | 35337019 | PubTator, text mining | PubMed |
| Metformin: Sex/Gender Differences in Its Uses and Effects-Narrative Review. | Medicina (Kaunas) | 2022 | 35334606 | PubTator, text mining | PubMed |
| Effects of Physical Prehabilitation on the Dynamics of the Markers of Endothelial Function in Patients Undergoing Elective Coronary Bypass Surgery. | J Pers Med | 2022 | 35330470 | PubTator, text mining | PubMed |
| Data-Independent Acquisition Enables Robust Quantification of 400 Proteins in Non-Depleted Canine Plasma. | Proteomes | 2022 | 35324581 | PubTator, text mining | PubMed |
| Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2. | Bioengineered | 2022 | 35322742 | PubTator, text mining | PubMed |
| Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells. | J Am Heart Assoc | 2022 | 35322667 | PubTator, text mining | PubMed |
| Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells. | Annu Rev Chem Biomol Eng | 2022 | 35320695 | PubTator, text mining | PubMed |
| An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo. | BMC Cardiovasc Disord | 2022 | 35317745 | PubTator, text mining | PubMed |
| Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates. | NPJ Regen Med | 2022 | 35304486 | PubTator, text mining | PubMed |
| The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy. | Clin Transl Med | 2022 | 35297182 | PubTator, text mining | PubMed |
| Differently Expressed Circular RNAs in Lacrimal Sacs From Patients With Chronic Dacryocystitis. | Front Genet | 2022 | 35295950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=39